Implantable BCIs are transitioning from moonshot demonstrations to tangible tools that restore lost function and address a variety of neurological disorders. With it, the focus of scientific discovery needs to be driven by the practical challenges posed by real life use. What is a realistic technological trajectory today - and what is possible tomorrow? What recent advances will enable widespread use of BCI for restoration? What objectives and areas should public and private investments focus on?

The answer to our waste and pollution challenges lies in nature. In nature, nothing is wasted, and we believe this principle can—and must—be applied to industry as well. Nature knows how to heal itself, but it may take hundreds or thousands of years to accomplish this unaided. We must act sooner. We can learn from nature and bring a new level of performance to its potential. Taking nature’s lead, advancing its evolution and combining it with existing proven treatment technologies and deployment models will enable the ability to redeem waste, liberate natural resources, and permanently remove harmful pollutants.

Discussion will focus on Wild Earth's immediate goals to advance the future of pet food in the plant-based and cell-based food space, including a brief look at our longevity research.

R2DIO ("radio") makes it easier to resolve signals and control noise by making every aspect of interdisciplinary R&D more traceable, more analyzable and more improvable. Our R2DIO Programs enable your team to capture more data with less work. Our R2DIO Tower makes R&D data accessible as SQL-queryable tables that are ready for visualization and rich statistical analysis.

NEED DESCRIPTION

Synbio has a software problem. Many companies aspire to be the, “AWS”, of synthetic biology but they’re all missing a massive critical piece of infrastructure. The core software and libraries to do it. AWS had Linux. They had Git. They had a vast bazaar of open source packages, databases, and languages to help them build their, “cloud”, but what does synbio have? Until now? Nothing but a few, old, abandoned python packages. That’s why I made Poly - the world’s most modern, open source, software library for engineering organisms. Already the most advanced synbio software on the open web, come learn how Poly can help your software team shine.

Phage therapy doesn’t work… yet. Since almost the moment of their discovery, phage has been touted as an antibacterial treatment, but after 100+ years we still don’t have a successful, generalizable phage therapy. At Felix, we are combining the awesome power of synthetic biology, machine learning, and evolutionary biology to finally crack the phage code.

Helaina is the first company leveraging precision fermentation to make human proteins with bioactive properties, previously only available in human milk. Helaina is utilizing bioactive proteins to deliver the first humanized infant formula capable of the same immunity benefits (antiviral, antibacterial, and antifungal) as breast milk. There are hundreds of applications for this technology outside of infant formula, and using fermentation to recreate bioactive ingredients is a sustainable and targeted way to deliver novel functional ingredients to all foods.

At Pall, we understand the uphill battle you are facing to deliver a robust, reproducible and scalable gene therapy viral vector process. We have the proven scalable technology, end-to-end integrated platforms, knowledge and services to help you get your gene therapy to market. Work with us to increase your speed to commercialization or to improve process productivity and deliver therapies to transform lives.